Advances in haploidentical hematopoietic stem cell transplantation: reports from the 56th American Society of Hematology annual meeting / 白血病·淋巴瘤

ABSTRACT

Haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) has been an alternative source of stem cell transplantation,the successful application of which makes each transplant candidate has his/her donor.In this paper,advances in the Haplo-HSCT reported in the 56th American Society of Hematology (ASH) annual meeting are reviewed.